The targeted NGS of 160,790 specimens from multiple cancers, including PCa, revealed that beyond BRCA1/2 genes, a strong association of the genome-wide loss of heterozygosity and biallelic mutations with PCa was found for BARD1, PALB2, and RAD51 paralogs [74]. The gene discussed is BRCA1; the disease is cancer.